USPTO serial 78246345
OPTIYIELD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WELLS, CHRISTOPHER
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OPTIYIELD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ANDREW F. ABRAMSON
ANDREW F ABRAMSON TESTA, HURWITZ & THIBEAULT, LLPHIGH ST TWR125 HIGH STBOSTON, MA 02110Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Gel cassettes with or without a base, safety cover, comb, electrode and power supply for clinical medical use; Microarray apparatus with or without slides, optical scanner and software for clinical medical use; Apparatus, namely microarrays for clinical medical use; Apparatus, namely gel cassettes for clinical or medical use in electrophoresis assays; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting analytes; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in purifying analytes analytes; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating analytes; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting nucleic acid sequences; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in purifying nucleic acid sequences; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating nucleic acid sequences; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in blood products; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in blood products; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting viral contamination in blood products; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in platelet products; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in platelet products; Apparatus for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in identifying bacterial pathogens; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect analytes; Apparatus kits for clinical medical use, namely kits comprised of microarrays and reagents; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify analytes; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate analytes; Apparatus kits for clinical medical use, namely kits comprised of gel cassettes and reagents used to detect nucleic acid sequences; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify nucleic acid sequences; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate nucleic acid sequences; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in blood products; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in blood products; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect viral contamination in blood products; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in platelet products; Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in platelet products; and Apparatus kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to identify bacterial pathogens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 17, 2003 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Nov 17, 2003 | PAPER RECEIVED | — | |
| Oct 14, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2003 | PAPER RECEIVED | — |